ENTRY       D12424                      Drug
NAME        Davutamig (USAN)
FORMULA     C6427H9906N1700O2030S45
EXACT_MASS  144821.1604
MOL_WEIGHT  144910.5195
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGTSLRL SCAASGFTFD DYAMHWVRQA PGKGLEWVSG ITWNSYNIDY
            ADSVKGRFTI SRDNAKNSLY LQMNSLRAED TALYYCAKDD DYSNYVYFDY WGQGTLVTVS
            SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEFLGGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE
            GNVFSCSVMH EALHNHYTQK SLSLSLGK
            (heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFIVT TNYMTWLRQA PGKGLEWVSL IYSSGHTYYA
            DSVKGRFTIS RHNSKNTLYL QMDSLRAEDT AVYYCASAFA ADVFDIWGQG TMVTVSSAST
            KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE FLGGPSVFLF
            PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTYRVV
            SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP SQEEMTKNQV
            SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD KSRWQEGNVF
            SCSVMHEALH NRFTQKSLSL SPGK
            (Lihgt chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPKLLIYA ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H135-L215, H148-H204, H227-h223, H230-h226, H262-H322, H368-H426, h22-h95, h131-L'215, h114-h200, h258-h318, h364-h422, L23-L88, L135-L195, L'23-L'88, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, biparatopic antibody
TARGET      MET [HSA:4233] [KO:K05099]
  PATHWAY   hsa04014(4233)  Ras signaling pathway
            hsa04151(4233)  PI3K-Akt signaling pathway
            hsa05200(4233)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               MET family
                MET
                 D12424  Davutamig (USAN)
DBLINKS     CAS: 2648058-48-2
///
